Abstract
In models of focal cerebral ischemia, adenoviral gene transfer is often attenuated or delayed versus naive. After controlled cortical impact (CCI)-induced traumatic brain injury in mice, CA1 and CA3 hippocampus exhibit delayed neuronal death by 3 days, with subsequent near complete loss of hippocampus by 21 days. We hypothesized that adenoviral-mediated expression of the reporter gene β-Galactosidase (β-Gal) in hippocampus would be attenuated after CCI in mice. C57BL6 mice (n = 16) were subjected to either CCI to left parietal cortex or sham (burr hole). Adenovirus carrying the β-Gal gene (AdlacZ; 1 x 10)9 plaque-forming units [pfu]/mL) was then injected into left dorsal hippocampus. At 24 or 72 h, β-Gal expression was quantified (mU/mg protein). Separate mice (n = 10) were used to study β-Gal spatial distribution in brain sections. β-Gal expression in left hippocampus was similar in shams at 24 h (48.4 ± 4.1) versus 72 h (68.8 ± 8.8, not significant). CCI did not reduce β-Gal expression in left hippocampus (68.8 ± 8.8 versus 88.1 ± 7.0 at 72 h, sham versus CCI, not significant). In contrast, CCI reduced β-Gal expression in right (contralateral) hippocampus versus sham (p < 0.05 at both 24 and 72 h). β-Gal was seen in many cell types in ipsilateral hippocampus, including CA3 neurons. Despite eventual loss of ipsilateral hippocampus, adenovirus-mediated gene transfer was surprisingly robust early after CCI providing an opportunity to test novel genes targeting delayed hippocampal neuronal death.
Original language | English |
---|---|
Pages (from-to) | 73-82 |
Number of pages | 10 |
Journal | Journal of Neurotrauma |
Volume | 18 |
Issue number | 1 |
DOIs | |
State | Published - 2001 |
Externally published | Yes |
Keywords
- Controlled cortical impact
- Gene therapy
- Head injury
- Vector